ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,069Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 917

$660K Total Retail Price of All Prescriptions

Rank: 53 out of 917

520 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 520 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 520 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 7,324 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
AMLODIPINE BESYLATE 454 360 1 5
SIMVASTATIN 341 250 2 2
LEVOTHYROXINE SODIUM 306 240 3 3
LISINOPRIL 293 223 4 1
OMEPRAZOLE 245 194 5 4
FUROSEMIDE 240 208 6 7
POTASSIUM CHLORIDE 226 172 7 16
HYDROCODONE-ACETAMINOPHEN 223 173 S3 8 6
METFORMIN HCL 197 103 9 8
TRAMADOL HCL 189 130 10 28
WARFARIN SODIUM 181 149 11 10
METOPROLOL SUCCINATE 147 131 12 18
PRAVASTATIN SODIUM 141 106 13 20
ZOLPIDEM TARTRATE 133 83 14 21
ATORVASTATIN CALCIUM 127 93 15 14
CITALOPRAM HBR 119 91 16 15
HYDROCHLOROTHIAZIDE 119 93 16 9
METOPROLOL TARTRATE 114 99 18 11
NAMENDA 108 108 19 43
CRESTOR 108 64 19 30
ATENOLOL 104 59 21 12
LOSARTAN POTASSIUM 94 82 22 13
CARVEDILOL 94 69 22 33
OXYCODONE-ACETAMINOPHEN 93 56 S2 24 46
GABAPENTIN 93 57 24 17
DOXAZOSIN MESYLATE 93 71 24 74
CYCLOBENZAPRINE HCL 92 44 R 27 65
SERTRALINE HCL 90 55 28 24
RANITIDINE HCL 90 55 28 29
ALLOPURINOL 89 87 30 31
DONEPEZIL HCL 84 84 31 32
POLYETHYLENE GLYCOL 3350 83 41 32 66
BACLOFEN 81 48 33 82
TRAZODONE HCL 79 44 34 22
PREDNISONE 76 58 35 34
OXYCODONE HCL 73 43 S2 36 27
RISPERIDONE 72 52 37 51
MORPHINE SULFATE ER 71 58 S2 38 48
PROAIR HFA 70 55 39 35
CYMBALTA 68 46 40 56
LEVETIRACETAM 65 47 41 120
JANUVIA 64 47 42 81
DIVALPROEX SODIUM 62 0 43 75
CLOPIDOGREL 58 52 44 50
FLUTICASONE PROPIONATE 57 27 45 26
LANTUS 57 34 45 37
ADVAIR DISKUS 56 50 47 47
MELOXICAM 55 47 48 53
COMBIVENT 54 52 49 148
LOVASTATIN 53 43 50 19
CEPHALEXIN 53 43 50 105
AMLODIPINE BESYLATE-BENAZEPRIL 53 22 50 181
SPIRIVA 52 44 53 45
DIGOXIN 51 28 54 41
TRIAMTERENE-HCTZ 51 23 54 36
INSULIN SYRINGE 50 24 56 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.